Zivo Bioscience Inc. Warrant 2023

Zivo Bioscience Inc. Warrant 2023 is a security that grants holders the right, but not the obligation, to purchase shares of Zivo Bioscience Inc.’s common stock at a fixed exercise price within a specified period. These warrants were issued as part of a registered direct offering and concurrent private placement designed to raise capital for the company’s ongoing research and development in biotechnology and agricultural technology. Each warrant—comprising Series A and Series B tranches—allows investors to acquire common shares at an exercise price of $2.80 per share, with Series A warrants exercisable for two years and Series B warrants for five years from the date of issuance. The main function of Zivo Bioscience Inc. Warrant 2023 is to provide existing and prospective investors with future exposure to the company’s equity at a predetermined price, often as an added incentive in fundraising initiatives. Zivo Bioscience Inc. focuses on the development of therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, targeting both human and animal health sectors. By offering warrants, the company can attract investment to advance its pipeline, while warrant holders gain the flexibility to participate in potential future growth by converting warrants into shares under defined conditions.